CervoMed, Inc. (CRVO)
4.54
+0.23
(+5.34%)
USD |
NASDAQ |
Mar 17, 16:00
4.54
0.00 (0.00%)
After-Hours: 18:39
CervoMed EPS Diluted (Quarterly) : -0.874 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
| Enzon Pharmaceuticals, Inc. | -0.0216 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.087M |
| Revenue (Quarterly) | 0.0087M |
| Total Expenses (Quarterly) | 8.096M |
| Enterprise Value | 19.01M |
| Profit Margin (Quarterly) | -92.96K% |
| Earnings Yield | -65.43% |
| Normalized Earnings Yield | -65.43 |